New Mesothelioma Test May Help in Diagnosis
| |

New Mesothelioma Test May Help in Diagnosis

Getting an accurate diagnosis is one of the biggest challenges for patients with malignant pleural mesothelioma.  Because mesothelioma is such an aggressive cancer, survival often hinges on getting a diagnosis and starting appropriate treatment as early as possible. Unfortunately, mesothelioma symptoms, which can include shortness of breath, cough and chest pain, mimic many other conditions, including other types of lung cancer. Now, scientists with a company called Rosetta Genomics, a developer of microRNA-based molecular diagnostics, believe they have found a better way to distinguish mesothelioma cancer from other types of lung cancers that may also affect the pleura, or the lining around the lungs. In an online press release, Tina Edmonston, MD, Medical Director and Head of Clinical Laboratory at…

New Mesothelioma Test May Detect Disease Earlier
| |

New Mesothelioma Test May Detect Disease Earlier

Malignant mesothelioma is on the rise around the world.  As with many cancers, early detection is the key to survival and better quality of life for patients.  Now, a group of Japanese researchers is paving the way for a laboratory test that could help doctors identify the disease – and start aggressive treatment – earlier. Writing in the journal, Modern Pathology, the researchers explain how a protein called CD146 can serve as a biomarker for mesothelioma.  The protein has already been shown to be present in patients with advanced malignant melanoma, prostate cancer and ovarian cancer.  Now, for the first time, researchers have also identified its presence in the lung fluid of mesothelioma patients. The research team tested the lung fluid of…